Literature DB >> 24296906

Genetic polymorphisms in calcitonin receptor gene and risk for recurrent kidney calcium stone disease.

Nasser Shakhssalim1, Abbas Basiri, Massoud Houshmand, Hamid Pakmanesh, Banafsheh Golestan, Mohaddeseh Azadvari, Hajar Aryan, Amir H Kashi.   

Abstract

INTRODUCTION: In this study the full sequence of the calcitonin receptor gene (CALCR) in a group of Iranian males suffering from recurrent calcium urinary stones was compared with that of a control group.
METHODS: Serum and urinary biochemistry related to urolithiasis were evaluated in 105 males diagnosed with recurrent kidney calcium stones and 101 age-matched healthy control males. The polymerase chain reaction single-strand conformation polymorphism method was used to detect new polymorphisms in the CALCR.
RESULTS: Nine polymorphisms were detected; seven were in the non-coding and two in the coding region. The T allele associated with the 3'UTR+18C>T polymorphism was observed exclusively in the stone formers. The exact odds ratio for the T allele in this locus for those at risk of stone formation was 36.72 (95% CI 4.95-272.0) (p < 0.001). The mean (standard deviation) urine calcium concentration was 117 (60) mg/l in patients with the C allele and 152 (72) mg/l in those with the T allele (p = 0.03). In addition, IVS1-6T>C and IVS1insA polymorphisms in intron 1 were associated with kidney stone disease (p < 0.001). Regarding single nucleotide polymorphism 447, mean (standard deviation) of serum calcitonin levels were 16.7 (18.7) pg/ml, 10.5 (11.0) pg/ml and 9.94 (9.7) pg/ml in subjects with TT, TC and CC genotypes, respectively (p = 0.01).
CONCLUSION: Our data indicate a potential association between 3'UTR+18C>T and intron 1 polymorphisms in the CALCR and the risk of kidney stone disease. 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24296906     DOI: 10.1159/000353348

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

1.  Association of TRPV5, CASR, and CALCR genetic variants with kidney stone disease susceptibility in Egyptians through main effects and gene-gene interactions.

Authors:  Fahmy T Ali; Eman M Abd El-Azeem; Hala F A Hekal; Mayada M El-Gizawy; Mohamed S Sayed; AbdAllah Y Mandoh; Ahmed F Soliman
Journal:  Urolithiasis       Date:  2022-09-11       Impact factor: 2.861

2.  Genetic polymorphisms as prognostic factors for recurrent kidney stones: A systematic review and meta-analysis.

Authors:  Widi Atmoko; Putu Angga Risky Raharja; Ponco Birowo; Agus Rizal Ardy Hariandy Hamid; Akmal Taher; Nur Rasyid
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

3.  Association of CASR, CALCR, and ORAI1 Genes Polymorphisms With the Calcium Urolithiasis Development in Russian Population.

Authors:  Maria M Litvinova; Kamil Khafizov; Vitaly I Korchagin; Anna S Speranskaya; Aliy Yu Asanov; Alina D Matsvay; Daniil A Kiselev; Diana V Svetlichnaya; Sevda Z Nuralieva; Alexey A Moskalev; Tamara V Filippova
Journal:  Front Genet       Date:  2021-05-12       Impact factor: 4.599

4.  Association between calcitonin receptor gene polymorphisms and calcium stone urolithiasis: A meta-analysis.

Authors:  Jiaxuan Qin; Zonglong Cai; Jinchun Xing; Bo Duan; Peide Bai
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.